NZ221647A - Di- and triblock copolymers comprising polyalkylene oxide block and a block comprising glycolic acid ester and trimethylene carbonate linkages; slow release drug delivery systems - Google Patents

Di- and triblock copolymers comprising polyalkylene oxide block and a block comprising glycolic acid ester and trimethylene carbonate linkages; slow release drug delivery systems

Info

Publication number
NZ221647A
NZ221647A NZ221647A NZ22164787A NZ221647A NZ 221647 A NZ221647 A NZ 221647A NZ 221647 A NZ221647 A NZ 221647A NZ 22164787 A NZ22164787 A NZ 22164787A NZ 221647 A NZ221647 A NZ 221647A
Authority
NZ
New Zealand
Prior art keywords
block
acid ester
drug delivery
delivery systems
glycolic acid
Prior art date
Application number
NZ221647A
Other languages
English (en)
Inventor
Donald James Casey
Louis Rosati
Peter Kendrick Jarrett
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/903,797 external-priority patent/US4716203A/en
Priority claimed from US06/903,801 external-priority patent/US4882168A/en
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NZ221647A publication Critical patent/NZ221647A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/64—Polyesters containing both carboxylic ester groups and carbonate groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Materials For Medical Uses (AREA)
NZ221647A 1986-09-05 1987-09-02 Di- and triblock copolymers comprising polyalkylene oxide block and a block comprising glycolic acid ester and trimethylene carbonate linkages; slow release drug delivery systems NZ221647A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/903,797 US4716203A (en) 1986-09-05 1986-09-05 Diblock and triblock copolymers
US06/903,801 US4882168A (en) 1986-09-05 1986-09-05 Polyesters containing alkylene oxide blocks as drug delivery systems

Publications (1)

Publication Number Publication Date
NZ221647A true NZ221647A (en) 1990-09-26

Family

ID=27129378

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ221647A NZ221647A (en) 1986-09-05 1987-09-02 Di- and triblock copolymers comprising polyalkylene oxide block and a block comprising glycolic acid ester and trimethylene carbonate linkages; slow release drug delivery systems

Country Status (13)

Country Link
EP (1) EP0258780B1 (https=)
KR (1) KR880003985A (https=)
AU (1) AU605172B2 (https=)
BR (1) BR8704648A (https=)
CA (1) CA1283988C (https=)
DE (1) DE3786309T2 (https=)
DK (1) DK462287A (https=)
ES (1) ES2058081T3 (https=)
FI (1) FI873840L (https=)
GR (1) GR3008526T3 (https=)
HU (1) HU205711B (https=)
IL (1) IL83764A (https=)
NZ (1) NZ221647A (https=)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9401703A (nl) * 1994-10-14 1996-05-01 Rijksuniversiteit Kauwgom.
US5702717A (en) * 1995-10-25 1997-12-30 Macromed, Inc. Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers
US5665428A (en) * 1995-10-25 1997-09-09 Macromed, Inc. Preparation of peptide containing biodegradable microspheres by melt process
DE19726412A1 (de) * 1997-06-21 1998-12-24 Merck Patent Gmbh Implantatmaterial mit einer Träger-Wirkstoff-Kombination
US6201072B1 (en) * 1997-10-03 2001-03-13 Macromed, Inc. Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
EP1034207B1 (en) * 1997-10-03 2005-03-02 Macromed Inc. BIODEGRADABLE LOW MOLECULAR WEIGHT TRIBLOCK POLY(LACTIDE-co-GLYCOLIDE) POLYETHYLENE GLYCOL COPOLYMERS HAVING REVERSE THERMAL GELATION PROPERTIES
US6117949A (en) * 1998-10-01 2000-09-12 Macromed, Inc. Biodegradable low molecular weight triblock poly (lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
US6004573A (en) * 1997-10-03 1999-12-21 Macromed, Inc. Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
US7662409B2 (en) 1998-09-25 2010-02-16 Gel-Del Technologies, Inc. Protein matrix materials, devices and methods of making and using thereof
US7018645B1 (en) 2000-04-27 2006-03-28 Macromed, Inc. Mixtures of various triblock polyester polyethylene glycol copolymers having improved gel properties
EA007772B1 (ru) * 2001-03-23 2007-02-27 Гумлинк А/С Разлагаемый заменитель смолы для жевательной резинки
CA2440016C (en) 2001-03-23 2010-12-14 Gumlink A/S Coated degradable chewing gum with improved shelf life and process for preparing same
WO2003000156A1 (en) 2001-06-22 2003-01-03 Southern Biosystems, Inc. Zero-order prolonged release coaxial implants
ES2304501T3 (es) 2002-02-15 2008-10-16 Nektar Therapeutics Al, Corporation Polimeros a base de oxido de alquileno degradables hidroliticamente.
CA2483778A1 (en) 2002-04-29 2003-11-13 Gel-Del Technologies, Inc. Biomatrix structural containment and fixation systems and methods of use thereof
EP1504047B1 (en) * 2002-05-03 2007-12-12 Janssen Pharmaceutica N.V. Polymeric microemulsions
US7649023B2 (en) 2002-06-11 2010-01-19 Novartis Ag Biodegradable block copolymeric compositions for drug delivery
ES2377318T3 (es) 2002-09-06 2012-03-26 Cerulean Pharma Inc. Polímeros a base de ciclodextrina para el suministro de los agentes terapéuticos enlazados covalentemente a ellos
EP1542542B2 (en) 2002-09-24 2013-09-04 Gumlink A/S Biodegradable chewing gum comprising at least one high molecular weight biodegradable polymer
CA2500976A1 (en) 2002-09-24 2004-04-08 Gumlink A/S Chewing gum comprising at least two different biodegradable polymers
EP1474993B1 (en) 2003-05-06 2008-08-20 Gumlink A/S A method for producing chewing gum granules and compressed gum products, and a chewing gum granulating system
EP1474995B1 (en) 2003-05-06 2012-11-14 Gumlink A/S A method for producing chewing gum granules, a gum composition extruder and granulating system, and a chewing gum product
US8465537B2 (en) 2003-06-17 2013-06-18 Gel-Del Technologies, Inc. Encapsulated or coated stent systems
WO2005034852A2 (en) 2003-08-26 2005-04-21 Gel-Del Technologies, Inc. Protein biomaterials and biocoacervates and methods of making and using thereof
WO2005055945A2 (en) 2003-12-08 2005-06-23 Gel-Del Technologies, Inc. Mucoadhesive drug delivery devices and methods of making and using thereof
US20080176958A1 (en) 2007-01-24 2008-07-24 Insert Therapeutics, Inc. Cyclodextrin-based polymers for therapeutics delivery
CA2711001A1 (en) 2007-12-26 2009-07-09 Gel-Del Technologies, Inc. Biocompatible protein-based particles and methods thereof
US10016534B2 (en) 2008-11-17 2018-07-10 Gel-Del Technologies, Inc. Protein biomaterial and biocoacervate vessel graft systems and methods of making and using thereof
AU2010295646B2 (en) 2009-09-15 2016-02-11 Ellipses Pharma Limited Treatment of cancer
US20110300150A1 (en) 2010-05-18 2011-12-08 Scott Eliasof Compositions and methods for treatment of autoimmune and other disease
US20140094432A1 (en) 2012-10-02 2014-04-03 Cerulean Pharma Inc. Methods and systems for polymer precipitation and generation of particles
EP4192509A1 (en) 2020-08-05 2023-06-14 Ellipses Pharma Ltd Treatment of cancer using a cyclodextrin-containing polymer-topoisomerase inhibitor conjugate and a parp inhibitor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3736646A (en) * 1971-10-18 1973-06-05 American Cyanamid Co Method of attaching surgical needles to multifilament polyglycolic acid absorbable sutures
US4047533A (en) * 1976-09-20 1977-09-13 American Cyanamid Company Absorbable surgical sutures coated with polyoxyethylene-polyoxypropylene copolymer lubricant
US4429080A (en) * 1982-07-01 1984-01-31 American Cyanamid Company Synthetic copolymer surgical articles and method of manufacturing the same
US4438253A (en) * 1982-11-12 1984-03-20 American Cyanamid Company Poly(glycolic acid)/poly(alkylene glycol) block copolymers and method of manufacturing the same
US4452973A (en) * 1982-11-12 1984-06-05 American Cyanamid Company Poly(glycolic acid)/poly(oxyethylene) triblock copolymers and method of manufacturing the same

Also Published As

Publication number Publication date
DK462287A (da) 1988-03-06
CA1283988C (en) 1991-05-07
HU205711B (en) 1992-06-29
ES2058081T3 (es) 1994-11-01
IL83764A (en) 1991-05-12
EP0258780A2 (en) 1988-03-09
HUT52945A (en) 1990-09-28
FI873840A0 (fi) 1987-09-04
EP0258780A3 (en) 1988-05-18
IL83764A0 (en) 1988-02-29
AU605172B2 (en) 1991-01-10
AU7797087A (en) 1988-03-10
DE3786309T2 (de) 1994-02-10
EP0258780B1 (en) 1993-06-23
KR880003985A (ko) 1988-05-31
DK462287D0 (da) 1987-09-04
GR3008526T3 (https=) 1993-10-29
FI873840A7 (fi) 1988-03-06
BR8704648A (pt) 1988-04-26
DE3786309D1 (de) 1993-07-29
FI873840L (fi) 1988-03-06

Similar Documents

Publication Publication Date Title
NZ221647A (en) Di- and triblock copolymers comprising polyalkylene oxide block and a block comprising glycolic acid ester and trimethylene carbonate linkages; slow release drug delivery systems
NZ231579A (en) Aerosol formulation containing a medicament and tetrafluoroethane
DE3372103D1 (en) Poly(glycolic acid)/poly(oxyethylene)triblock copolymers and method of manufacturing the same
NZ225394A (en) A tablet having improved bioadhesion to mucous membranes comprising a biopolymer and a polyol
AU8235591A (en) Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon
NZ221411A (en) Pharmaceutical compositions containing microcapsules and a surfactant
AU638768B2 (en) Pharmaceutical and cosmetic depigmentation compositions with a caffeic acid base
NZ216662A (en) Capsule made from polyalkylene glycol and poly(ethylene oxide)
NZ221306A (en) 2-component immunoadjuvant comprising a mycobacterial free immunoadjuvant oil and a polycationic polyelectrolyte immunoadjuvant and vaccines thereof
AU3511889A (en) Pyridonecarboxylic acids and antibacterial agents
IL84105A0 (en) 1-tertiary-alkyl-substituted naphthyridine-and quinoline-carboxylic acids and salts thereof and pharmaceutical compositions containing them
EP0584876A3 (en) Low diol polyalkylene oxide biologically active proteinaceous substances
NZ224046A (en) Hiv antigenic peptide fragments and their use
IL87800A0 (en) Dioxolane-2-carboxylic acids and pharmaceutical compositions comprising them
GB2224932B (en) Pharmaceutical solutions comprising cromoglycic acid and salbutamol
EP0410422A3 (en) A highly absorbable pharmaceutical composition
EP0336661A3 (en) Wipes for use in a cleanroom and a method of making them
AU4675989A (en) Rare earth oxides and a process for their preparation
NZ227669A (en) Amino acid glycerides and pharmaceutical compositions thereof
NZ226446A (en) Pharmaceutical composition comprising a piperidinoalkanol derivative, nonionic surfactants and calcium carbonate
ZA893123B (en) Novel processes and products involving yttrium-alkaline earth-bismuth-copper oxides
IL82726A (en) Pharmaceutical compositions comprising anticonvulsively active 1-phenalkylimidazole-4-and/or-5-carboxamides and certain novel phenalkylimidazoles and their manufacture
IL92854A0 (en) Controlled release,low-dose aspirin formulation and its preparation
AU5125390A (en) Substituted (quinolin-2-yl-methoxy)phenyl-n,n'- sulphonylureas, processes for their preparation and their use in medicaments
GB2204790B (en) Pharmaceutical compositions comprising a quinoline dicarboxylic acid and an anticholinergic agent